Arkolith/Insider Trading/INAB/Form 4

Rochlin Kate

Chief Operating OfficerIN8BIO, INC. (INAB) · full profile →Form 4 · filed May 7, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
1 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 30, 2025Option exercise(M)12K$0.18$2K55K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 30, 2025Option exercise(M)12K—$00
Apr 27, 2025Grant(A)12K——12K
Apr 27, 2025Disposed to issuer(D)12K——0
Apr 27, 2025Grant(A)12K——12K
Apr 27, 2025Disposed to issuer(D)12K——0

Transaction Codes

M
Option exercise / conversion
A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-012289) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML